The company is adding Bioventus Active Healing Therapies and Bioventus Surgical, which will include the OsteoAMP allogeneic bone with endogenous growth factors used in spinal fusions. There are additional products expected for Bioventus Surgical in the near future.
Bioventus Active Healing consists of these products:
• EXOGEN Ultrasound Bone Healing System for non-unions and fresh fractures
• SUPARTZ, a joint fluid hyaluronic acid to treat knee pain from osteoarthritis
• DUROLANE, a single-injection joint fluid based on NASHA technology
The company will also continue pre-clinical progress on the bone morphogenetic protein assets acquired from Pfizer in 2013. EXOGEN, SUPARTZ and OsteoAMP are sold in the United States. DUROLANE isn’t available in the United States, but otherwise available worldwide.
More articles on orthopedic devices:
Implanet JAZZ Band cost-effective for scoliosis surgery—6 key notes
Vistek Medical reaches product manufacturing milestone of 2M
Medacta to showcase new surgical solutions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
